Health Care & Life Sciences » Biotechnology | Vertex Pharmaceuticals Inc.

Vertex Pharmaceuticals Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
687,550.00
742,745.00
588,181.00
84,031.00
91,635.00
2,106
Depreciation, Depletion & Amortization
48,365.00
63,257.00
62,343.00
61,398.00
61,397.00
72
Other Funds
1,252.00
2,160.00
-
75,000.00
8,234.00
366
Funds from Operations
46,519.00
502,136.00
279,482.00
238,173.00
829,678.00
1,032
Changes in Working Capital
5,051.00
11,063.00
85,950.00
2,070.00
15,264.00
238
Net Operating Cash Flow
51,570.00
513,199.00
365,432.00
236,103.00
844,942.00
1,270
Capital Expenditures
51,393.00
51,445.00
45,302.00
56,570.00
259,421.00
Purchase/Sale of Investments
32,319.00
133,766.00
332,421.00
149,891.00
163,367.00
Net Investing Cash Flow
82,014.00
72,321.00
257,171.00
73,321.00
422,352.00
Issuance/Reduction of Debt, Net
83,742.00
220,601.00
3,327.00
9,959.00
284,670.00
Net Financing Cash Flow
180,884.00
497,376.00
188,919.00
133,271.00
68,404.00
Net Change in Cash
52,008.00
54,322.00
77,824.00
438,029.00
496,796.00
Free Cash Flow
102,963.00
564,400.00
410,734.00
179,540.00
745,521.00
Deferred Taxes & Investment Tax Credit
285,053.00
281.00
3,283.00
16,961.00
120,513.00
1,512
Net Assets from Acquisitions
-
10,000.00
-
-
-
Other Sources
1,698.00
-
52.00
-
436.00
Change in Capital Stock
265,878.00
274,615.00
185,592.00
68,230.00
344,840.00
Exchange Rate Effect
4,708.00
2,176.00
2,834.00
4,666.00
5,802.00
Other Uses
-
-
30,000.00
20,000.00
-

About Vertex Pharmaceuticals

View Profile
Address
50 Northern Avenue
Boston Massachusetts 02210
United States
Employees -
Website http://www.vrtx.com
Updated 07/08/2019
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S.